Title: Juma'a Raheem Al Dulayymi: Innovator in Mycobacterial Disease Diagnosis
Introduction
Juma'a Raheem Al Dulayymi is a notable inventor based in Great Britain. He has made significant contributions to the field of medical diagnostics, particularly in the detection of mycobacterial diseases. His innovative approach aims to improve the accuracy and efficiency of diagnosing these infections.
Latest Patents
Juma'a holds a patent titled "Composition And Method For The Diagnosis Of Mycobacterial Disease." This method involves determining whether an individual is infected with a mycobacterial disease through a systematic approach. The process includes providing a system that comprises an antigen, contacting this system with a sample obtained from the individual, and detecting the presence or absence of binding of a biomarker in the sample with the antigen. The antigen used in this method is a mycolic acid wax ester derived antigen. Although he currently has 0 patents, his work is pivotal in advancing diagnostic methods.
Career Highlights
Juma'a Raheem Al Dulayymi is associated with Diagnostig Ltd., where he applies his expertise in medical diagnostics. His role at the company allows him to collaborate with other professionals in the field, enhancing the development of innovative diagnostic solutions.
Collaborations
Some of Juma'a's coworkers include Mark Stephen Baird and Christopher David Gwenin. Their collective efforts contribute to the advancement of diagnostic technologies and methodologies.
Conclusion
Juma'a Raheem Al Dulayymi is a dedicated inventor whose work in the diagnosis of mycobacterial diseases showcases his commitment to improving healthcare. His innovative methods have the potential to significantly impact the field of medical diagnostics.